Cyclodextrin-based targeting strategies for tumor treatment.

Area of Science:

• Biomedical Engineering
• Drug Delivery
• Nanotechnology

Background:

• Anticancer drug efficacy is limited by systemic toxicity and drug resistance.
• Targeted drug delivery systems aim to overcome chemotherapy's shortcomings.
• Current strategies focus on enhancing drug specificity and reducing side effects.

Purpose of the Study:

• To review ligand-attached cyclodextrin-based complexes as a promising drug delivery system.
• To explore strategies for targeting drug carriers to pathological sites.
• To highlight the role of molecular interactions in targeted delivery.

Main Methods:

• Review of existing literature on cyclodextrin-based drug delivery systems.
• Analysis of targeting tactics, including conjugation and encapsulation.
• Examination of bioactive substances used in these complexes.

Main Results:

• Ligand-attached cyclodextrin complexes offer a promising approach for targeted anticancer drug delivery.
• Specific molecular interactions between drugs and cell surface receptors are key to targeting.
• Various bioactive substances can be incorporated into cyclodextrin-based systems.

Conclusions:

• Cyclodextrin-based supramolecules, polymers, and nanoparticles represent a viable strategy for advanced drug delivery.
• Targeting moieties enhance the specificity of drug carriers, improving therapeutic outcomes.
• Further development of these systems could significantly advance chemotherapy.